CalciMedica appoints Stephen Bardin as CFO; Dan Geffken resigns as interim CFO

CalciMedica, Inc.

Dan Geffken resigned as interim CFO effective after filing Q3 2024 10-Q.
Stephen Bardin appointed CFO, principal financial and accounting officer; previously a consultant since April 2024.
Bardin served as CFO of ATAI Life Sciences (2022-2024) and SVP Finance at BridgeBio (2022).
Compensation: $380k base salary, $20k signing bonus, 100k stock option and 40k RSUs granted.
Option vests 25% on Oct 1, 2025 then monthly; RSUs vest 25% on Oct 1, 2025 then quarterly.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Dan Geffken

interim Chief Financial Officer

CALC · CalciMedica, Inc.

Successor: Stephen Bardin
Filed: November 8, 2024, 6:59 PM ET

Dan Geffken tendered his resignation as interim Chief Financial Officer, principal financial officer and principal accounting officer of CalciMedica, Inc.

Appointed

Stephen Bardin

Chief Financial Officer

CALC · CalciMedica, Inc.

Filed: November 8, 2024, 6:59 PM ET

the Company’s board of directors (the “Board”) appointed Stephen Bardin as the Company’s Chief Financial Officer, as well as the Company’s principal financial officer and principal accounting officer effective as of the Effective Date.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Dan Geffken resigned as interim Chief Financial Officer at CalciMedica, Inc..

Action: resigned
Role: interim Chief Financial Officer

Exact text from the filing

Dan Geffken tendered his resignation as interim Chief Financial Officer, principal financial officer and principal accounting officer of CalciMedica, Inc.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Stephen Bardin was appointed as Chief Financial Officer at CalciMedica, Inc..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

the Company’s board of directors (the “Board”) appointed Stephen Bardin as the Company’s Chief Financial Officer, as well as the Company’s principal financial officer and principal accounting officer effective as of the Effective Date.

View on SEC.gov

CalciMedica, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-24-253754

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.